Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004
about
Hepatitis C Infection Among Injecting Drug Users in England and Wales (1992-2006): There and Back Again?Hepatitis-C multimedia prevention program in poor Hispanic HIV-infected injecting drug users: six months after intervention.Ending hepatitis C in the United States: the role of screening.High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillanceSocio-Economic Status Determines Risk of Receptive Syringe Sharing Behaviors among Iranian Drug Injectors; A National StudyDeveloping and validating a scoring tool for identifying people who inject drugs at increased risk of hepatitis C virus infection.The role of social networks and geography on risky injection behaviors of young persons who inject drugs.Descriptive Aspects of Injection Drug Users in Iran's National Harm Reduction Program by Methadone Maintenance Treatment.Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran.Imprisonment of opioid-dependent people in New South Wales, Australia, 2000–2012: a retrospective linkage study.Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Older injectors: an emerging and under-recognised public health issue.Risk factors for and incidence of acute hepatitis C after the achievement of blood supply safety in Italy: results from the national surveillance system.Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.Reduction in Needle Sharing Among Seattle-Area Injection Drug Users Across 4 Surveys, 1994-2013.
P2860
Q27488973-D2096CB3-3BCF-450A-ABF6-3BF539D57C32Q33809640-030E86B9-F13B-4C81-AAF1-BD9C4822F4F4Q33862919-3949207B-4AC0-4766-9294-88CE1C78B93FQ35120376-CB44FED2-D482-48EB-8BE6-21F28D1E820FQ35206950-1D489A7D-107E-4D3A-9A60-8EF1EF367052Q35659866-413861AF-8DD1-4C53-9E5C-A0481CCC5883Q36701887-4C100EC2-F132-4DF2-84B2-93FF66F71598Q37097128-E3D47CC6-C6D0-4D39-A051-799B9B75B709Q37470458-E36149B9-E1BF-419F-B846-E6E47479075FQ41072782-FB82BAC8-B681-4DD8-A583-4BF4FCC9FF44Q42720607-DF110DB0-C309-4D30-A94E-A2DBCB47DE81Q43011090-E8E74F52-5BE8-4AF1-8A31-7500CB5F3863Q45710827-871A0039-CC2C-4B8B-9AD4-60648031E869Q51405910-7C364782-3466-4342-B300-E24C6BF0D7D4Q53647794-7455E704-224E-4A70-B9F1-B2989DF5BFBC
P2860
Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@ast
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@en
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@nl
type
label
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@ast
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@en
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@nl
prefLabel
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@ast
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@en
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@nl
P2860
P1476
Hepatitis C virus acquisition ...... endees in Australia, 1995-2004
@en
P2093
John M Kaldor
collaboration of Australian Needle and Syringe Programs
P2860
P2888
P304
P356
10.1007/S11524-008-9330-7
P577
2008-11-01T00:00:00Z